Clinical Trial Update: Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing homologous versus heterologous third vaccination in kidney transplant recipients with COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Complication

Snippet

Sponsor: Medical University of Vienna | Conditions: COVID-19 | Phase 2 | Status: UNKNOWN